- £242.42m
- £217.42m
- £48.70m
Holding(s) in Company
INTERIM RESULTS
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
PDMR/PCA Shareholding
Brief: Niox Group Reports 20% Revenue Growth To £25.2M In H1
Trading Update
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Brief: Astrazeneca Holds 15.86% Stake In Niox Group As Of May 20, Says Filing
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Block Listing Application
Holding(s) in Company
Exercise of Options, Director Dealing and TVR